0.78 (2.96%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Neutral
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Strong
Website
Beam Therapeutics, Inc.
Telephone
1.857.327.8775
Address
9th floor, 238 Main Street, Cambridge, MA 02142-1016
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 15.35 - 36.44
Trade Value (12mth)
US$13,207,644.00
1 week
-5.73%
1 month
-14.21%
YTD
-2.98%
1 year
52.9%
All time high
138.52
EPS 3 yr Growth
-80.40%
EBITDA Margin
-258.60%
Operating Cashflow
-$345m
Free Cash Flow Return
-30.50%
ROIC
-7.10%
Interest Coverage
0.00
Quick Ratio
13.10
Shares Outstanding (Fully Diluted)
103m
HALO Sector
Healthcare
Next Company Report Date
02-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 07 May 26 | |
| 07 May 26 | |
| 07 May 26 | |
| 06 March 26 | |
| 06 March 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -1.72 | -4.58 | -0.81 | | | | ||
EPS (Fully Diluted) | $ | | | | | -1.72 | -4.58 | -0.81 | | | | ||
Growth | % | | | | | 58.4 | -166.5 | 82.3 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
